Premium
The microRNAs, MiR‐31 and MiR‐375, as candidate markers in Barrett's esophageal carcinogenesis
Author(s) -
Leidner Rom S.,
Ravi Lakshmeswari,
Leahy Patrick,
Chen Yanwen,
Bednarchik Beth,
Streppel Mirte,
Canto Marcia,
S.Wang Jean,
Maitra Anirban,
Willis Joseph,
Markowitz Sanford D.,
BarnholtzSloan Jill,
Adams Mark D.,
Chak Amitabh,
Guda Kishore
Publication year - 2012
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.21934
Subject(s) - microrna , barrett's esophagus , dysplasia , carcinogenesis , metaplasia , cancer research , adenocarcinoma , downregulation and upregulation , biology , pathology , cancer , medicine , gene , genetics
Abstract There is a critical need to identify molecular markers that can reliably aid in stratifying esophageal adenocarcinoma (EAC) risk in patients with Barrett's esophagus. MicroRNAs (miRNA/miR) are one such class of biomolecules. In the present cross‐sectional study, we characterized miRNA alterations in progressive stages of neoplastic development, i.e., metaplasia–dysplasia–adenocarcinoma, with an aim to identify candidate miRNAs potentially associated with progression. Using next generation sequencing (NGS) as an agnostic discovery platform, followed by quantitative real‐time PCR (qPCR) validation in a total of 20 EACs, we identified 26 miRNAs that are highly and frequently deregulated in EACs (≥4‐fold in >50% of cases) when compared to paired normal esophageal squamous (nSQ) tissue. We then assessed the 26 EAC‐derived miRNAs in laser microdissected biopsy pairs of Barrett's metaplasia (BM)/nSQ ( n = 15), and high‐grade dysplasia (HGD)/nSQ ( n = 14) by qPCR, to map the timing of deregulation during progression from BM to HGD and to EAC. We found that 23 of the 26 candidate miRNAs were deregulated at the earliest step, BM, and therefore noninformative as molecular markers of progression. Two miRNAs, miR‐31 and −31*, however, showed frequent downregulation only in HGD and EAC cases suggesting association with transition from BM to HGD. A third miRNA, miR‐375, showed marked downregulation exclusively in EACs and in none of the BM or HGD lesions, suggesting its association with progression to invasive carcinoma. Taken together, we propose miR‐31 and −375 as novel candidate microRNAs specifically associated with early‐ and late‐stage malignant progression, respectively, in Barrett's esophagus. © 2012 Wiley Periodicals, Inc.